| RS1555254256 |
SACS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Spastic paraplegia |
| RS1555254439 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1555254489 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1555254734 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1555255328 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1555255676 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1555256440 |
SUCLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS1555257069 |
POMP
|
Health Risk |
Likely pathogenic |
— |
| RS1555257073 |
POMP
|
Health Risk |
Pathogenic |
Proteasome-associated autoinflammatory syndrome 2, Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome |
| RS1555257075 |
POMP
|
Health Risk |
Pathogenic |
Proteasome-associated autoinflammatory syndrome 2, Proteasome-associated autoinflammatory syndrome 2 |
| RS1555257076 |
POMP
|
Health Risk |
Pathogenic |
Proteasome-associated autoinflammatory syndrome 2, Proteasome-associated autoinflammatory syndrome 2 |
| RS1555257383 |
RNASEH2B
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 2, Aicardi-Goutieres syndrome 2 |
| RS1555258369 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial isolated restrictive cardiomyopathy, Hypertrophic cardiomyopathy 10 |
| RS1555260207 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS1555260833 |
FREM2
|
Health Risk |
Pathogenic |
— |
| RS1555261304 |
FREM2
|
Health Risk |
Pathogenic |
Fraser syndrome 2, Fraser syndrome 2 |
| RS1555262375 |
ALDH18A1
|
Health Risk |
Pathogenic |
ALDH18A1-related de Barsy syndrome, Cutis laxa |
| RS1555263116 |
SPART
|
Health Risk |
Likely pathogenic |
— |
| RS1555263787 |
ATP8A2
|
Health Risk |
Likely pathogenic |
— |
| RS1555264243 |
ALDH18A1
|
Health Risk |
Likely pathogenic |
ALDH18A1-related de Barsy syndrome, ALDH18A1-related de Barsy syndrome |
| RS1555264685 |
UNG
|
Health Risk |
Likely pathogenic |
— |
| RS1555267558 |
PTPN11
|
Health Risk |
Likely pathogenic |
RASopathy, Noonan syndrome 1 |
| RS1555267839 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555268564 |
PUS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, lactic acidosis |
| RS1555268712 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555269154 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555269488 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555269815 |
UBE3B
|
Health Risk |
Pathogenic |
Oculocerebrofacial syndrome, Kaufman type |
| RS1555270066 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555270113 |
PTPN11
|
Health Risk |
Pathogenic |
— |
| RS1555270321 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555270428 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555271215 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555271217 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555271298 |
POLR1D
|
Health Risk |
Likely pathogenic |
— |
| RS1555271308 |
POLR1D
|
Health Risk |
Pathogenic |
— |
| RS1555271865 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555271868 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555273567 |
CLN5
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis 5 |
| RS1555273604 |
CLN5
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1555273609 |
CLN5
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis 5 |
| RS1555273881 |
CLN5
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 5 |
| RS1555273882 |
CLN5
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis 5 |
| RS1555273992 |
CLN5
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS1555274005 |
CLN5
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis 5 |
| RS1555274014 |
CLN5
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis 5 |
| RS1555274254 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS1555274312 |
CLN5
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis 5 |
| RS1555274337 |
CLN5
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis 5 |
| RS1555274338 |
CLN5
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS1555274343 |
CLN5
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS1555274344 |
CLN5
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS1555274365 |
CLN5
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS1555274369 |
CLN5
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS1555274373 |
CLN5
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS1555274387 |
CLN5
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis 5 |
| RS1555274484 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS1555274493 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS1555274496 |
MMAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS1555274497 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS1555275604 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS1555276160 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS1555277061 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Mucolipidosis type II |
| RS1555277081 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1555277827 |
COG6
|
Health Risk |
Pathogenic |
COG6-congenital disorder of glycosylation, COG6-congenital disorder of glycosylation |
| RS1555279195 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1555279210 |
RB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1555279212 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1555279228 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1555279757 |
MVK
|
Health Risk |
Conflicting classifications of pathogenicity |
Mevalonic aciduria, Hyperimmunoglobulin D with periodic fever |
| RS1555279958 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555279969 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555280053 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS1555280073 |
BRCA2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast neoplasm |
| RS1555280093 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555280096 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant tumor of breast, Hereditary breast ovarian cancer syndrome |
| RS1555280102 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555280115 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1555280325 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1555280326 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555280333 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555280340 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555280354 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555280367 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555280374 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555280383 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555280388 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555280404 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555280423 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555280425 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555280427 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555280838 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1555280839 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1555280840 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555280845 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1555280854 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555280855 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555280859 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1555280869 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1555280870 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |